Public Availability of Advisory Committee Members' Financial Interest Information and Waivers: Guidance for the Public, FDA Advisory Committee Members, and FDA Staff
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
February 28, 2014
April 21, 2019
88d3e93e-8c53-4bbb-a7f5-e8ffb0e2a655
Related Documents
Guidance for Hospitals, Nursing Homes, and Other Health Care Facilities - FDA Public Health Advisory: Guidance for Hospitals, Nursing Homes, and Other Health Care Facilities
Guidance DocumentApril 5, 2001Center for Drug Evaluation and Research
Temporary Policies for Compounding Certain Parenteral Drug Products: Guidance for Industry
Guidance DocumentOctober 11, 2024Center for Drug Evaluation and Research
The Open Public Hearing at FDA Advisory Committee Meetings: Guidance for the Public, FDA Advisory Committee Members, and FDA Staff
Guidance DocumentMay 15, 2013Office of the Commissioner
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox